U.S. Markets open in 3 hrs 11 mins
  • S&P Futures

    3,634.00
    +6.75 (+0.19%)
     
  • Dow Futures

    29,883.00
    +55.00 (+0.18%)
     
  • Nasdaq Futures

    12,196.25
    +44.00 (+0.36%)
     
  • Russell 2000 Futures

    1,842.70
    -1.90 (-0.10%)
     
  • Crude Oil

    45.15
    -0.56 (-1.23%)
     
  • Gold

    1,813.00
    +1.80 (+0.10%)
     
  • Silver

    23.36
    -0.09 (-0.37%)
     
  • EUR/USD

    1.1923
    +0.0010 (+0.0835%)
     
  • 10-Yr Bond

    0.8780
    -0.0040 (-0.45%)
     
  • Vix

    21.41
    -0.23 (-1.06%)
     
  • GBP/USD

    1.3366
    +0.0009 (+0.0682%)
     
  • USD/JPY

    104.0010
    -0.2490 (-0.2388%)
     
  • BTC-USD

    16,760.52
    -406.13 (-2.37%)
     
  • CMC Crypto 200

    327.69
    -42.83 (-11.56%)
     
  • FTSE 100

    6,318.14
    -44.79 (-0.70%)
     
  • Nikkei 225

    26,644.71
    +107.40 (+0.40%)
     

Bronstein, Gewirtz & Grossman, LLC Notifies MultiPlan Corporation (MPLN) Shareholders of Investigation

·2 min read

NEW YORK, NY / ACCESSWIRE / November 17, 2020 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of MultiPlan Corporation ("MultiPlan" or the "Company") (NASDAQ:MPLN). Investors who purchased MultiPlan securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/mpln.

The investigation concerns whether MultiPlan and certain of its officers and/or directors have violated federal securities laws.

On November 11, 2020, Muddy Waters Research ("Muddy Waters") released a report entitled "MultiPlan: Private Equity Necrophilia Meets The Great 2020 Money Grab." Among other issues, the Muddy Waters report asserted that Multiplan is "in financial decline, and its financial statements were engineered to obscure this existing deterioration" and that the Company "is in the process of losing its largest client, UnitedHealthcare (‘UHC')," which "has formed a competitor to MultiPlan that offers significantly lower prices and fewer conflicts of interest." On this news, Multiplan's stock price fell $1.72 per share, or 19.7%, to close at $7.01 per share on November 11, 2020.

If you are aware of any facts relating to this investigation, or purchased MultiPlan shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/mpln. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC



View source version on accesswire.com:
https://www.accesswire.com/617146/Bronstein-Gewirtz-Grossman-LLC-Notifies-MultiPlan-Corporation-MPLN-Shareholders-of-Investigation